NAVIDEA BIOPHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Navidea Biopharmaceuticals, Inc. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
  • Navidea Biopharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$5.71M, a 134% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$15.2M, a 29.4% decline from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$11.7M.
  • Navidea Biopharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2016 was -$14.3M, a 48.1% increase from 2015.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$15.2M -$3.45M -29.4% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 -$11.7M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2016 -$14.3M +$13.3M +48.1% Jan 1, 2016 Dec 31, 2016 8-K 2017-12-15
2015 -$27.6M +$8.16M +22.8% Jan 1, 2015 Dec 31, 2015 8-K 2017-12-15
2014 -$35.7M +$6.97M +16.3% Jan 1, 2014 Dec 31, 2014 8-K 2017-12-15
2013 -$42.7M -$13.5M -46.4% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-16
2012 -$29.2M -$34.8M -619% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $5.61M +$55.6M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 -$50M Jan 1, 2010 Dec 31, 2010 10-K/A 2013-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.